IU Health opens expanded clinical 3D Print Studio for surgical planning in Indianapolis
Originally reported by 3Druck
Indiana University Health (IU Health) has opened an expanded 3D Print Studio at the 16 Tech Innovation District in Indianapolis, designed to produce patient-specific anatomical models for diagnostics, surgical planning, and patient education. Developed in collaboration with Ricoh 3D for Healthcare, the program leverages clinically validated workflows incorporating direct surgeon feedback. The studio uses FDA-cleared anatomical models for selected surgical and radiation therapy applications, relying on Ricoh’s Managed Services platform to ensure regulatory compliance. IU Health reports that the use of 3D-printed models has reduced average operative time by approximately 60 minutes per case, translating to less anesthesia exposure, reduced blood loss, and more predictable surgical outcomes.
This expansion reflects a broader trend of point-of-care 3D printing moving from pilot projects to embedded clinical infrastructure. Unlike centralized service bureaus, hospital-based studios allow surgeons to iterate rapidly on patient-specific models and cutting guides without external lead times. Medical-dental continues to be one of AM’s most production-credible verticals, driven by tangible clinical ROI: shorter surgeries, improved patient communication, and defensible cost savings. The IU Health case underscores that the real barrier to adoption is no longer the printer hardware but the regulatory and workflow integration layer, which Ricoh’s Managed Services platform directly addresses by handling data validation, process control, and FDA compliance. This mirrors the pattern seen in larger hospital systems such as Mayo Clinic and Cleveland Clinic, where point-of-care AM studios have become standard for complex orthopedic and oncologic cases.
The operative metric here is the 60-minute reduction in surgical time, which provides a clear economic justification for the studio’s capital and operational costs. For hospital administrators evaluating similar investments, this data point anchors the ROI conversation in measurable outcomes rather than technological potential. IU Health’s next challenge will be scaling this capability from high-complexity cases to broader surgical volumes while maintaining the same quality control and turnaround times.
Topics